Industry › BioTech
Press Releases
SinoMab Announces that IND Application of SM17 for the Treatment of Asthma was Approved by NAMP
SinoMab BioScience Limited
Aug 14, 2023 21:10 HKT/SGT
CanariaBio Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination with Niraparib in the Treatment of Recurrent Ovarian Cancer
CanariaBio Inc
Aug 08, 2023 15:00 HKT/SGT
Eisai Listed for 22nd Consectutive Year In FTSE4Good Index Series, An Index for Socially Responsible Investment
Eisai
Aug 04, 2023 12:04 HKT/SGT
Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held
Legend Capital
Jul 31, 2023 19:48 HKT/SGT
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
Peptomyc SL
Jul 28, 2023 06:00 HKT/SGT
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed
Essex Bio-Technology Limited
Jul 26, 2023 18:58 HKT/SGT
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
HanchorBio Inc
Jul 24, 2023 20:19 HKT/SGT
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
HanchorBio Inc
Jul 24, 2023 19:30 HKT/SGT